<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Community:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/232" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/232</id>
  <updated>2026-04-07T16:07:42Z</updated>
  <dc:date>2026-04-07T16:07:42Z</dc:date>
  <entry>
    <title>Hormonal gynaecological disorders associated with viral hepatitis</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/25160" />
    <author>
      <name>Stavinskaia, Liudmila</name>
    </author>
    <author>
      <name>Friptu, Valentin</name>
    </author>
    <author>
      <name>Dumbrava, Vlada</name>
    </author>
    <author>
      <name>Tabuica, Uliana</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/25160</id>
    <updated>2023-07-18T09:34:54Z</updated>
    <published>2016-01-01T00:00:00Z</published>
    <summary type="text">Title: Hormonal gynaecological disorders associated with viral hepatitis
Authors: Stavinskaia, Liudmila; Friptu, Valentin; Dumbrava, Vlada; Tabuica, Uliana</summary>
    <dc:date>2016-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Early onset of intrahepatic cholestasis of pregnancy: a case report</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/25159" />
    <author>
      <name>Cemortan, Maria</name>
    </author>
    <author>
      <name>Stavinskaia, Liudmila</name>
    </author>
    <author>
      <name>Sagaidac, Irina</name>
    </author>
    <author>
      <name>Cernetchi, Olga</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/25159</id>
    <updated>2023-07-18T09:09:38Z</updated>
    <published>2022-01-01T00:00:00Z</published>
    <summary type="text">Title: Early onset of intrahepatic cholestasis of pregnancy: a case report
Authors: Cemortan, Maria; Stavinskaia, Liudmila; Sagaidac, Irina; Cernetchi, Olga</summary>
    <dc:date>2022-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Application of hormonal contraceptive preparations for patients with liver pathology</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/25158" />
    <author>
      <name>Stavinskaia, L.</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/25158</id>
    <updated>2023-07-18T08:28:04Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Title: Application of hormonal contraceptive preparations for patients with liver pathology
Authors: Stavinskaia, L.</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Noi viziuni  în tratamentul contemporan al  dereglărilor funcţiei menstruale la pacientele cu hepatite virale</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/25157" />
    <author>
      <name>Stavinskaia, Liudmila</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/25157</id>
    <updated>2023-07-17T12:43:31Z</updated>
    <published>2007-01-01T00:00:00Z</published>
    <summary type="text">Title: Noi viziuni  în tratamentul contemporan al  dereglărilor funcţiei menstruale la pacientele cu hepatite virale
Authors: Stavinskaia, Liudmila
Abstract: În studiul prezent au fost cercetate rezultatele tratamentului dereglărilor funcţiei menstruale la 80 de paciente alese aleator din totalul de 319 bolnave cu hepatită cronică virală. Alegerea preparatu-lui hormonal s-a efectuat în funcţie de dereglările ciclului menstrual, profi lul hormonal şi rezultatele ultrasonografi ei organelor bazinului mic. Rezultatele studiului peste 3 luni de la debutul tratamentului au demonstrat că alegerea metodei pentru corecţia dereglărilor funcţiei menstruale depinde de gradul activităţii hepatitei virale şi de durata acestor dereglări. Duphastonul  reprezintă preparatul de elecţie pentru reglarea funcţiei menstruale la femeile cu hepatită cu grade minim şi moderat de activitate, fa-vorizând restabilirea rapidă a ciclului menstrual în 82,6% cazuri. Femostonul  este un remediu indicat pentru redresarea dereglărilor hormonale grave, provocate de acutizarea hepatitei cronice B sau C sau  de hepatita mixtă B+D, forma moderată sau gravă. Efi cacitatea înaltă a terapiei cu Femoston a fost observată la 67,74% de bolnave [RR=0,51; IC=0,34±0,098; X2=5,02(p&lt;0,05)]. Cercetările clinice au arătat lipsa efectelor nedorite ale Femostonului şi  Duphastonului asupra metabolismului glucidelor, lipidelor şi a funcţiei hepatice, ceea ce este important în cazul administrării îndelungate a preparatelor pe fondul unei patologii hepatice cronice.; In the present study, we considered the results of the menstrual dysfunctions treatment of 80 patients,  accidentally  selected  out  of  a  total  of  319  patients  suffering  from  viral  chronic  hepatitis.  The  selection  of  the  hormonal  preparation  was  made  depending  on  the  menstrual  irregularities,  hormonal profile and results of the genitals ultrasonography. The results of the study after 3 months from the beginning of the treatment showed that the selection of the method for correcting menstrual irregularities depends of the degree of the viral hepatitis activity and length of these abnormalities. Duphaston  is  the  selected  preparation  for  correcting  the  menstrual  function  at  women  with  the  minimum and moderate hepatitis activity degree, favouring the quick recovery of the menstrual cycle in  82.6%  of  cases.  Femoston  is  recommended  for  the  recovery  of  serious  hormonal  dysfunctions,  caused by the acute condition of the B or C chronic hepatitis or B+D mixed hepatitis, moderate or severe forms. The high efficiency of the Femoston therapy was observed in 67.74% of cases [RI=0,51; IC=0,34±0,098; X2=5,02(p&lt;0,05)]. The  clinical  researches  showed  the  lack  of  adverse  effects of the Femoston and Duphaston  therapies  over  the  metabolism of glucides,  lipids  and  hepatic  function,  which  is  important  for  the  long-term administration of preparations on the background of a chronic hepatic disease.</summary>
    <dc:date>2007-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

